Literature DB >> 31100570

Sodium perchlorate induces non-alcoholic fatty liver disease in developing stickleback.

Michael R Minicozzi1, Frank A von Hippel2, Christoff G Furin3, C Loren Buck2.   

Abstract

Perchlorate is a pervasive, water-soluble contaminant that competitively inhibits the sodium/iodide symporter, reducing the available iodide for thyroid hormone synthesis. Insufficient iodide uptake can lead to hypothyroidism and metabolic syndromes. Because metabolism, obesity and non-alcoholic fatty liver disease (NAFLD) are tightly linked, we hypothesized that perchlorate would act as an obesogen and cause NAFLD via accumulation of lipids in liver of developing threespine stickleback (Gasterosteus aculeatus). We performed an upshift/downshift exposure regime (clean water to perchlorate treated water or perchlorate treated water to clean water) on stickleback embryos at two concentrations (30 mg/L and 100 mg/L) plus the control (0 mg/L) over the course of 305 days. Adult stickleback were euthanized, H&E stained and analyzed for liver morphology. Specifically, we counted the number of lipid droplets, and measured the area of each droplet and the total lipid area of a representative section of liver. We found that perchlorate treated fish had more and larger lipid droplets, and a larger percentage of lipid in their liver than control fish. These data indicate that perchlorate causes NAFLD and hepatic steatosis in stickleback at concentrations commonly found at contaminated sites. These data also indicate the potential of perchlorate to act as an obesogen. Future studies should investigate the obesogenic capacity of perchlorate by examining organ specific lipid accumulation and whether perchlorate induces these effects at concentrations commonly found in drinking water. Work is also needed to determine the mechanisms by which perchlorate induces lipid accumulation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endocrine disruption; Environmental obesogen; Lipid accumulation; Liver; Sodium perchlorate

Mesh:

Substances:

Year:  2019        PMID: 31100570      PMCID: PMC6768070          DOI: 10.1016/j.envpol.2019.05.001

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  48 in total

1.  Effects of ammonium perchlorate on the reproductive performance and thyroid follicle histology of zebrafish.

Authors:  Reynaldo Patiño; Melody R Wainscott; Emilia I Cruz-Li; Saravanan Balakrishnan; Cynthia McMurry; Vicki S Blazer; Todd A Anderson
Journal:  Environ Toxicol Chem       Date:  2003-05       Impact factor: 3.742

Review 2.  'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.

Authors:  Amedeo Lonardo; Cesare Carani; Nicola Carulli; Paola Loria
Journal:  J Hepatol       Date:  2006-04-05       Impact factor: 25.083

Review 3.  Body fat distribution, insulin resistance, and metabolic diseases.

Authors:  P Björntorp
Journal:  Nutrition       Date:  1997-09       Impact factor: 4.008

4.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 5.  Developmental exposure to endocrine disruptors and the obesity epidemic.

Authors:  Retha R Newbold; Elizabeth Padilla-Banks; Ryan J Snyder; Terry M Phillips; Wendy N Jefferson
Journal:  Reprod Toxicol       Date:  2007-01-17       Impact factor: 3.143

6.  Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

Authors:  Savino Bruno; Patrick Maisonneuve; Paola Castellana; Nicole Rotmensz; Sonia Rossi; Marco Maggioni; Marcello Persico; Alberto Colombo; Franco Monasterolo; Donata Casadei-Giunchi; Franco Desiderio; Tommaso Stroffolini; Virgilio Sacchini; Andrea Decensi; Umberto Veronesi
Journal:  BMJ       Date:  2005-03-03

7.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

8.  Scientific decision making, policy decisions, and the obesity pandemic.

Authors:  James R Hebert; David B Allison; Edward Archer; Carl J Lavie; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2013-06       Impact factor: 7.616

9.  Hepatic morphology in obesity.

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

10.  Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice.

Authors:  Raquel Chamorro-García; Margaret Sahu; Rachelle J Abbey; Jhyme Laude; Nhieu Pham; Bruce Blumberg
Journal:  Environ Health Perspect       Date:  2013-01-15       Impact factor: 9.031

View more
  2 in total

1.  Evolution and developmental expression of the sodium-iodide symporter (NIS, slc5a5) gene family: Implications for perchlorate toxicology.

Authors:  Ann M Petersen; Clayton M Small; Yi-Lin Yan; Catherine Wilson; Peter Batzel; Ruth A Bremiller; C Loren Buck; Frank A von Hippel; William A Cresko; John H Postlethwait
Journal:  Evol Appl       Date:  2022-07-07       Impact factor: 4.929

2.  Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.

Authors:  Michael R Minicozzi; Erik G Axlid; Frank A von Hippel; Joseph Espinoza; Aubrey Funke; Quentin P Phillips; C Loren Buck
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.